759825

0

CURIS

img img img img
No Data Available

Curis Lifesciences Ltd Share Price Update

As of the latest trading session, Curis Lifesciences Ltd share price is currently at ₹102, which is down by ₹-2.00 from its previous closing. Today, the stock has fluctuated between ₹102.00 and ₹102.05. Over the past year, Curis Lifesciences Ltd has achieved a return of [-]%. In the last month alone, the return has been -15.48%.

Curis Lifesciences Ltd performance

Today’s low

Today’s high

₹ 102.00 ₹ 102.05
₹ 104.00

52 week low

52 week high

₹ 98.00 ₹ 147.90
₹ 104.00

Open Price

₹ 102.05

Prev. Close

₹ 104.00

Volume (Shares)

1000.00

Total traded value

₹ 1.04

Upper Circuit

₹ 124.80

Lower Circuit

₹ 83.20

info

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Curis Lifesciences Ltd fundamentals


  • Market cap (Cr)

    84.10

  • P/E Ratio (TTM)

    13.77

  • Beta

    0.78

  • Book Value / share

    54.11

  • Return on equity

    55.32%

  • EPS (TTM)

    7.55

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.34

info icon alternate text
  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text

Curis Lifesciences Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 8.41
Operating Expense 0.00
Net Profit 1.34
Net Profit Margin (%) 15.93
Earnings Per Share (EPS) 2.26
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 19.50
Operating Expense 15.79
Net Profit 2.87
Net Profit Margin (%) 14.71
Earnings Per Share (EPS) 4.84
EBITDA 4.24
Effective Tax Rate (%) 22.84
Particulars MAR 2025 (Values in Cr)
Revenue 50.26
Operating Expense 41.30
Net Profit 6.21
Net Profit Margin (%) 12.35
Earnings Per Share (EPS) 10.87
EBITDA 10.77
Effective Tax Rate (%) 30.92
Particulars MAR 2024 (Values in Cr)
Revenue 35.56
Operating Expense 28.70
Net Profit 4.87
Net Profit Margin (%) 13.69
Earnings Per Share (EPS) 97.34
EBITDA 8.70
Effective Tax Rate (%) 32.21
Particulars MAR 2023 (Values in Cr)
Revenue 35.50
Operating Expense 34.21
Net Profit 1.12
Net Profit Margin (%) 3.15
Earnings Per Share (EPS) 22.44
EBITDA 3.68
Effective Tax Rate (%) 30.86
Particulars MAR 2022 (Values in Cr)
Revenue 23.74
Operating Expense 22.63
Net Profit 0.78
Net Profit Margin (%) 3.28
Earnings Per Share (EPS) 15.63
EBITDA 3.48
Effective Tax Rate (%) 29.72
Particulars MAR 2025 (Values in Cr)
Book Value / Share 27.34
ROE % 55.32
ROCE % 34.13
Total Debt to Total Equity 1.48
EBITDA Margin 20.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 117.46
ROE % 152.90
ROCE % 40.46
Total Debt to Total Equity 5.38
EBITDA Margin 24.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 6.45
ROE % 246.00
ROCE % 16.48
Total Debt to Total Equity 0.00
EBITDA Margin 10.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share -18.07
ROE % 98.00
ROCE % 15.66
Total Debt to Total Equity 0.00
EBITDA Margin 15.16
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 42.53
Total Liabilities 42.53
Total Equity 16.22
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 14.35
Return on Capital (%) 19.17
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 33.81
Total Liabilities 33.81
Total Equity 5.67
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 15.84
Return on Capital (%) 23.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 29.66
Total Liabilities 29.66
Total Equity 0.32
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.13
Return on Capital (%) 7.42
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 27.39
Total Liabilities 27.39
Total Equity -0.90
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.79
Return on Capital (%) 2.94
Particulars MAR 2024 (Values in Cr)
Net Income 7.22
Cash from Operations 1.73
Cash from Investing -0.06
Cash from Financing 0.04
Net change in Cash 0.26
Free Cash Flow 1.81
Particulars MAR 2023 (Values in Cr)
Net Income 1.54
Cash from Operations 3.34
Cash from Investing -0.54
Cash from Financing -2.75
Net change in Cash 0.04
Free Cash Flow 3.96
Particulars MAR 2022 (Values in Cr)
Net Income 1.22
Cash from Operations 4.94
Cash from Investing -0.37
Cash from Financing -4.57
Net change in Cash 0.00
Free Cash Flow 5.34
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 12.37 1.48 219.02 23.12 / 52.00
BLISS GVS PHARMA LTD 217.80 20.82 2.03 2304.08 105.05 / 225.00
CIPLA LTD 1330.85 22.61 3.26 107503.49 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 310.90 10.34 2.34 915.01 219.00 / 399.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 23.24 3.98 219.02 23.12 / 52.00
AMRUTAJAN HEALTH LTD 632.15 31.61 5.34 1827.59 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8878.75 106.70 27.78 22196.88 6501.60 / 10653.05
BLISS GVS PHARMA LTD 217.80 29.67 2.08 2304.08 105.05 / 225.00

Curis Lifesciences Ltd shareholding pattern

Holding

18.1%
68.03%
2.93%
10.93%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Curis Lifesciences Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
104.00 0.00 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 105.70
  • 26 Days 111.00
  • 10 Days 106.50
  • 50 Days 116.30
  • 12 Days 107.00
  • 100 Days 119.50
  • 20 Days 109.30
  • 200 Days 119.50
106.63 PIVOT

First Support

103.47

First Resistance

108.22

Second Support

101.88

Second Resistance

111.38

Third Support

98.72

Third Resistance

112.97

RSI

38.89

ADX

44.48

MACD

-4.06

Williams % R

-53.85

Commodity Channel Index (CCI)

-61.23

Date

2026-02-13

Week

1750.00

Same Day

1000.00

Month

6143.00

1 Year

0.78

3 Year

0.79

Over 1 Month

-15.48%

down

Over 1 Year

0.00%

down

Over 3 Months

-26.24%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Curis Lifesciences Ltd Corporate Actions

Top Gainers

Curis Lifesciences Ltd Share Price

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad. Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar.

Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic. The business is majorly on product to product basis with different marketers. Company has commenced manufacturing facility in year 2017, hence, it has experience of more than 7 years in the current line of business of the Company. The manufacturing facility of the Company is installed with capacity to manufacture 138 Crore tables / year, 15.75 Crore Capsules / year, 1,080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45 Tons sterile ophthalmic ointment / year. It deal in Pharmaceutical products like Tablets, Capsules, External Preparations, Oral Liquid, Sterile Ophthalmic Ointments etc.

The Company's past and present clientele includes renowned pharma marketers and manufactures namely Arova Pharma, Express Pharmaceuticals Private Limited, Angle Biogenics Private Limited, Centurion Healthcare Private Limited, Costcon Healthcare LLP, J.B. Chemical & Pharmaceuticals Limited, Venus international, Makers Laboratories Limited and Torikaa Pharmaceuticals Limited etc. pharmaceutical manufacturing facility are situated at Sanand GIDC-II in Ahmedabad district of Gujarat, which offers easy and convenient accessibility.

Company launched the IPO by raising a fresh issue of Rs 27.52 Crore and issued 21,50,000 equity shares of Rs 10 by way of IPO in Nov'25.

Parent organization Indian Private
NSE symbol CURIS
Founded 2016
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Curis Lifesciences Ltd?

Answer Field

Curis Lifesciences Ltd share price is for NSE ₹ 102.00 & for BSE ₹ 0.00 as on Feb 16 2026 09:45 AM.

What is the Market Cap of Curis Lifesciences Ltd Share?

Answer Field

The market cap of Curis Lifesciences Ltd for NSE ₹ 84.10 & for BSE ₹ 0.00 as on Feb 16 2026 09:45 AM.

What is the 52 Week High and Low of Curis Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Curis Lifesciences Ltd for NSE is ₹ 147.90 and ₹ 98.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Curis Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Curis Lifesciences Ltd Share?

Answer Field

As on Feb 16 2026 09:45 AM the price-to-earnings (PE) ratio for Curis Lifesciences Ltd share is 13.77.

What is the PB ratio of Curis Lifesciences Ltd Share?

Answer Field

As on Feb 16 2026 09:45 AM, the price-to-book (PB) ratio for Curis Lifesciences Ltd share is 54.11.

How to Buy Curis Lifesciences Ltd Share?

Answer Field

You can trade in Curis Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Curis Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Curis Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Curis Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59